Myosteatose

Myosteatose refers to a pathological condition characterized by the replacement of muscle tissue with fat, leading to a reduction in muscle mass and strength. This process typically occurs as part of the natural aging process, known as sarcopenic obesity, but it can also result from various medical conditions or disuse atrophy. The term combines "myo," derived from the Greek word for muscle, and "steatose," which relates to fat accumulation within tissues.

In myosteatose, fat infiltrates muscle fibers, disrupting their structure and function. This infiltration can be observed through imaging techniques such as MRI or CT scans, which reveal abnormal fat deposits within the muscle. The condition is often associated with decreased physical performance, metabolic disturbances, and an increased risk of chronic diseases like diabetes and cardiovascular disorders.

Several factors contribute to the development of myosteatose, including prolonged immobilization, hormonal imbalances (such as low testosterone or thyroid hormone levels), chronic diseases (e.g., kidney failure or cancer), and certain medications (e.g., corticosteroids). Lifestyle factors, including sedentary behavior and poor nutrition, may also play a role. Diagnosis typically involves clinical evaluation, imaging studies, and sometimes muscle biopsies to confirm fat infiltration.

Management of myosteatose focuses on reversing muscle loss and reducing fat accumulation. Exercise, particularly resistance training, is considered the most effective intervention to preserve muscle mass and improve function. A balanced diet rich in protein and adequate caloric intake supports muscle maintenance, while avoiding excessive fat intake helps mitigate fat infiltration. In some cases, medical or surgical treatments may be required to address underlying conditions contributing to the condition. Early intervention is key to preventing further deterioration in muscle and overall health.